Anh T. Le

Mechanisms of Resistance to Crizotinib in Patients with <i>ALK</i> Gene Rearranged Non–Small Cell Lung Cancer

Robert C. Doebele, Amanda Pilling, Dara L. Aisner et al. · Clinical Cancer Research · 2012 · 1.1K citations · Full text

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · The Lancet Oncology · 2015 · 791 citations

Oncology, Gastrointestinal Oncology, Cancer Management +8

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

Aria Vaishnavi, Marzia Capelletti, Anh T. Le et al. · Nature Medicine · 2013 · 582 citations · Full text

Oncogenic Agent, Pathology, Cancer Genetics +3

Identifying and Targeting <i>ROS1</i> Gene Fusions in Non–Small Cell Lung Cancer

Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro et al. · Clinical Cancer Research · 2012 · 454 citations · Full text

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Jacqulyne Robichaux, Yasir Y. Elamin, Zhi Tan et al. · Nature Medicine · 2018 · 443 citations · Full text

Tumor Biology, Oncology, Kinase Inhibitor +12